Ever wondered what makes you different from others? Cherished or disliked, why do you have specific features or traits that set you apart?  The answers lie in the fascinating fields of genomics and proteomics, which are like the keys to unlock the secrets of your unique existence. In the rapidly

JULY 9, 2023: A review of 13 trials using a genotype-first strategy in patient care was done by National Institutes of Health (NIH) researchers. In contrast to the conventional phenotype-first method, which begins with clinical observations, the genotype-first approach focuses on identifying patients with specific genomic variations and subsequently studying

12 June 2023: Syncona Ltd has introduced its third gene therapy company Beacon Therapeutics Holdings Ltd. Beacon Therapeutics will bring together two preclinical ophthalmologic programs owned by Syncona with Applied Genetic Technologies Corp's (AGTC's) advanced X-linked retinitis pigmentosa (XLRP) program. Syncona has allocated £75 million to Beacon, which includes the

New York, 17 May, 2023: A new study contributes to an emerging and transformative understanding of how bacterial cells continually repair flawed segments within their DNA. Published in a research article, Journal Cell, researchers have unveiled a newly discovered DNA repair mechanism. This mechanism specifically targets the erroneous inclusion of